Although accumulating evidence clarifies that the abnormal overexpression of SHC1 may indicate the worst expected outcome in diverse types of cancers, including breast cancer10 and clear cell renal cell carcinoma,15 they neglect the impact of SHC1 expression level on NSCLC patients. This evidence concerns the gene SHC1 and clear cell renal carcinoma.